EUVIMEDEUVIMED entdecken
Crossref

Optimizing Mirabegron Stability in Human Plasma: Method Development, Validation Through Integration of Esterase Inhibitors and Stabilizers

Santosh Tawari iD, Ujashkumar Shah

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Santosh Tawari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India. Hauptthemen laut MEDLINE: Acetanilides, Thiazoles, Enzyme Inhibitors, Esterases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The stability of mirabegron in human plasma is addressed in this study. The susceptibility of Mirabegron to enzymatic and oxidative degradation requires the integration of esterase inhibitors and stabilizers into the analytical process. Esterase inhibitors, including sodium fluoride and dichlorvos, as well as stabilizing agents such as malic acid, ascorbic acid, acetic acid, citric acid and sodium bicarbonate were also investigated to mitigate this issue. Samples were prepared through solid‐phase extraction (SPE) utilizing Strata‐X cartridges. The optimization of chromatographic separation was conducted using a C18 Kromasil column with a solvent mixture consisting of ammonium formate and acetonitrile. Detection employed electrospray ionization (ESI) in positive ionization mode, focusing on MRM transitions of 397.2 → 260.1 for mirabegron and 402.2 → 260.1 for mirabegron D5. The method exhibited an accuracy range of 95.67% to 102.85% and precision of 0.52% to 2.31% for a linearity ranged from 0.100 to 102.496 ng/mL. An advantage of this method is its stability, requiring only a minimal plasma volume of 100 μL, a quick runtime of 3 min, and a high recovery rate of 92.93%, making it highly efficient and reliable for bioequivalence testing, therapeutic monitoring and pharmacokinetic studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetanilidesThiazolesEnzyme InhibitorsEsterasesHumansReproducibility of ResultsDrug StabilityLinear ModelsLimit of DetectionSolid Phase ExtractionChromatography, High Pressure Liquid

Stichwörter der Autor:innen

LCMShuman plasmamirabegronmirabegron D5sodium fluoride

Substanzen

mirabegronAcetanilidesThiazolesEnzyme InhibitorsEsterases

Autor:innen und Institutionen

  • Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India.

ORCID-Profile: Santosh Tawari

Zitieren

APA

Tawari, S., & Shah, U. (2025). Optimizing Mirabegron Stability in Human Plasma: Method Development, Validation Through Integration of Esterase Inhibitors and Stabilizers. Biomedical Chromatography. https://doi.org/10.1002/bmc.70065

Vancouver

Tawari S, Shah U. Optimizing Mirabegron Stability in Human Plasma: Method Development, Validation Through Integration of Esterase Inhibitors and Stabilizers. Biomedical Chromatography. 2025. doi:10.1002/bmc.70065

BibTeX
@article{Tawari2025,
  author = {Tawari, Santosh and Shah, Ujashkumar},
  title = {Optimizing Mirabegron Stability in Human Plasma: Method Development, Validation Through Integration of Esterase Inhibitors and Stabilizers},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70065}
}
Kostenlos starten →